Search Results 351-360 of 16716 for alt

  1. PRGN-3006 Adoptive Cellular Therapy for CD33-Positive Relapsed or Refractory AML, MRD Positive AML or Higher Risk MDS - Mayo Clinic

    - Alanine aminotransferase (AST) and aspartate aminotransferase (ALT) < 3.0 x ULN. - Ejection fraction measured by echocardiogram (ECHO) or multi gated ...

  2. Rheumatoid arthritis cohort biorepository - Clinical Trials

    Chronic active liver disease (AST>144 IU/L or ALT>165 IU/L); Oral warfarin group medications or history of blood clotting disorders; Pregnancy or ...

  3. Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3) - Mayo Clinic

    Bilirubin > 1.5 x Upper Limit of Normal (ULN); AST and/or ALT > 2.5 x ULN; and; Serum creatinine > 1.5 x ULN. History of significant cardiovascular disease ...

  4. Phase 1 Study of Intradermal LV305 in Patients With Locally Advanced, Relapsed or Metastatic Cancer Expressing NY-ESO-1 - Mayo Clinic

    Hepatic: alanine aminotransferase (ALT), and aspartate aminotransferase (AST) > 2.5 x ULN, total serum bilirubin > 1.5 x ULN (patients with Gilbert's ...

  5. Erlotinib Hydrochloride In Reducing Duodenal Polyp Burden In Patients With Familial Adenomatous Polyposis At Risk Of Developing Colon Cancer - Mayo Clinic

    ALT/SGPT ≤ 2 x institutional upper limit of normal (ULN);; Creatinine ≤ institutional upper limit of normal (ULN);; Urinary testing results within ...

  6. A Study of TAS-120 in Patients with Advanced Solid Tumors - Mayo Clinic

    ... ALT ≤ 5 × ULN;; Total bilirubin ≤ 1.5 × ULN, or ≤ 3.0 mg/dL for patients with Gilbert's syndrome;; International normalized ratio (INR) <1.3 (or < 3.0 on ...

  7. Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer - Mayo Clinic

    Aspartate aminotransferase (AST)/alanine aminotransferase (ALT) ≤ 2.5 x ULN; Albumin ≥ 2.8 g/dL; Serum creatinine ≤ 1.5 x ULN, OR calculated creatinine ...

  8. Study Evaluating ABT-199 in Subjects With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    AST and ALT ≤3 × upper limit of normal range (ULN);; Calculated creatinine clearance ≥30 mL/min using a modified Cockcroft-Gault calculation or a 24-hour ...

  9. Phase 2 Study Of ALXN2030 In Patients With Antibody-Mediated Rejection After Kidney Transplantation - Mayo Clinic

    * ALT or AST > 2.0 × ULN * Total bilirubin > 2 × ULN (participants with Gilbert's syndrome can be included with total bilirubin > 2 × ULN as long as direct ...

  10. A Study of the Safety, Tolerability, and Effectiveness of GS-9674 for Adults with Primary Sclerosing Cholangitis without Cirrhosis - Mayo Clinic

    Alanine aminotransferase (ALT) > 10 x ULN; Total bilirubin > 2 x ULN; International normalized ratio (INR) > 1.2 unless on anticoagulant therapy; Small-duct ...